Hologic Inc. (NASDAQ: HOLX) is -2.85% lower on its value in year-to-date trading and has touched a low of $59.78 and a high of $80.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HOLX stock was last observed hovering at around $74.26 in the last trading session, with the day’s gains setting it 0.12% off its average median price target of $77.00 for the next 12 months. It is also 17.36% off the consensus price target high of $90.00 offered by 19 analysts, but current levels are -9.71% lower than the price target low of $67.80 for the same period.
Currently trading at $74.38, the stock is 2.32% and 10.00% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.08 million and changing 0.16% at the moment leaves the stock 4.35% off its SMA200. HOLX registered 0.04% gain for a year compared to 6-month loss of -2.13%.
The stock witnessed a 13.91% gain in the last 1 month and extending the period to 3 months gives it a 4.50%, and is 0.11% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.88% over the week and 2.57% over the month.
Hologic Inc. (HOLX) has around 6944 employees, a market worth around $18.46B and $4.86B in sales. Current P/E ratio is 14.53 and Fwd P/E is 19.02. Profit margin for the company is 26.80%. Distance from 52-week low is 24.42% and -7.59% from its 52-week high. The company has generated returns on investments over the last 12 months (17.50%).
Hologic Inc. (HOLX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Hologic Inc. (HOLX) is a “Overweight”. 19 analysts offering their recommendations for the stock have an average rating of 2.30, where 10 rate it as a Hold and 2 think it is a “Overweight”. 7 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Hologic Inc. is expected to release its quarterly report on 02/01/2023.The EPS is expected to shrink by -28.80% this year
Hologic Inc. (HOLX) Top Institutional Holders
The shares outstanding are 250.28M, and float is at 247.83M with Short Float at 3.37%.
Hologic Inc. (HOLX) Insider Activity
A total of 9 insider transactions have happened at Hologic Inc. (HOLX) in the last six months, with sales accounting for 2 and purchases happening 7 times. The most recent transaction is an insider sale by Thornal Kevin R, the company’s Group Pres, Global Diagnostics. SEC filings show that Thornal Kevin R sold 19,118 shares of the company’s common stock on Nov 15 at a price of $75.32 per share for a total of $1.44 million. Following the sale, the insider now owns 62368.0 shares.
Hologic Inc. disclosed in a document filed with the SEC on Nov 14 that Griffin John M. (General Counsel) sold a total of 26,902 shares of the company’s common stock. The trade occurred on Nov 14 and was made at $76.12 per share for $2.05 million. Following the transaction, the insider now directly holds 0.17 million shares of the HOLX stock.
Still, SEC filings show that on Nov 11, MACMILLAN STEPHEN P (Chairman, President and CEO) disposed off 138,422 shares at an average price of $75.71 for $10.48 million. The insider now directly holds 2,443,825 shares of Hologic Inc. (HOLX).
Hologic Inc. (HOLX): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 10.16% up over the past 12 months and Abbott Laboratories (ABT) that is -14.83% lower over the same period. Medtronic plc (MDT) is -30.31% down on the 1-year trading charts.